MARKET OVERVIEW:

The global interventional radiology market was valued at USD 28.10 billion in 2024 and is projected to grow to USD 47.28 billion by 2033, with a CAGR of 5.95% from 2025 to 2033. Interventional radiology (IR) utilizes imaging techniques such as X-ray fluoroscopy, CT, MRI, and ultrasound to guide minimally invasive procedures. It is increasingly favored for its cost-effectiveness, reduced risk, and lessened recovery time compared to traditional surgeries, particularly in fields like oncology, cardiology, and urology.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019-2024
• FORECAST YEAR: 2025-2033

INTERVENTIONAL RADIOLOGY MARKET KEY TAKEAWAYS:

• The interventional radiology market size was USD 28.10 billion in 2024 and is forecasted to reach USD 47.28 billion by 2033, growing at a CAGR of 5.95% from 2025 to 2033.
• Increasing demand for minimally invasive procedures across multiple medical fields, including cardiology and oncology, is driving market growth.
• Technological advancements, such as real-time imaging and augmented reality, are enhancing the effectiveness of interventional radiology.
• The growing prevalence of chronic diseases, especially related to sedentary lifestyles, is a major growth driver.
• Rising healthcare expenditures and government initiatives promoting IR techniques are contributing to market expansion.

MARKET GROWTH FACTORS:

Technological Advancements:

The continuous evolution of imaging technologies is crucial for the growth of interventional radiology. Innovations such as real-time imaging and augmented reality give radiologists an immersive dynamic view of internal organs, increasing procedure accuracy and success rate. Adding AI to identify abnormalities in medical images fits seamlessly into the diagnostic and procedural planning stream, making interventional radiology work more simply and reliably.

Increased Adoption of Minimally Invasive Procedures:

The globally accepted principle of moving toward minimally invasive procedures is yet another factor for the growing demand of the market. They are less expensive and less traumatic when compared to traditional methods of surgery, offering faster recovery times and lesser overall risks to patients. An added factor fuelling this demand for IR treatments is the growing inclination toward outpatient care and reduced hospital stays across various subspecialties such as cardiology, urology, and oncology.

Rising Prevalence of Chronic Diseases:

Chronic illnesses such as cardiovascular ailments, cancers, and kidney disease have a growing global market for interventional radiology. A growing sedentary lifestyle and unhealthy dietary habits increase the incidence of such conditions, which in turn will support the need for effective means for treatment. Interventional radiology is a shot across the bow for a number of chronic conditions, improving patient outcomes and helping health systems cope with these growing health dilemmas.

MARKET SEGMENTATION:

• Breakup by Product:
  • Magnetic Resonance Imaging (MRI): Uses magnetic fields to provide detailed images of internal structures.
  • Ultrasound Imaging Systems: Employs sound waves to create images of organs and tissues.
  • Computed Tomography (CT) Scanners: Provides detailed cross-sectional images, aiding in diagnosis and treatment planning.
  • Angiography Systems: Used for visualizing the inside of blood vessels and organs.
  • Fluoroscopy Systems: Real-time X-ray imaging to guide minimally invasive procedures.
  • Biopsy Devices: Instruments used for tissue sampling during diagnostic procedures.
  • Others: Includes various specialized devices for different IR procedures.
• Breakup by Procedures:
  • Angiography: Procedure to visualize blood vessels and diagnose conditions like aneurysms and blockages.
  • Angioplasty: A procedure to open blocked or narrowed arteries.
  • Embolization: Involves blocking blood flow to specific areas, often used in cancer treatment.
  • Vertebroplasty: A procedure to stabilize compressed vertebrae in the spine.
  • Thrombolysis: The dissolution of blood clots within blood vessels.
  • Nephrostomy Placement: Involves placing a tube to drain urine from the kidneys.
  • Others: Includes additional IR procedures for diverse medical conditions.
• Breakup by Application:
  • Cardiology: Utilizes IR for diagnosing and treating heart and vascular conditions.
  • Urology and Nephrology: Focuses on kidney-related diseases and treatments.
  • Oncology: Targets the use of IR in cancer diagnosis and treatment, including tumor ablation.
  • Gastroenterology: Involves treatments for gastrointestinal disorders.
  • Others: Covers additional medical fields utilizing IR.
• Breakup by End Use:
  • Hospitals: Primary setting for IR procedures, offering advanced technology and expert care.
  • Clinics: Smaller healthcare settings providing specialized IR services.
  • Ambulatory Surgical Centers: Outpatient facilities for minimally invasive procedures.
• Breakup by Region:
  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

REGIONAL INSIGHTS:

North America has the most significant region for interventional radiology marketing due to increased healthcare spending and sophisticated medical infrastructure implementation of emerging minimally invasive procedures. Herein, the U.S. and Canada lead the phenomenal growth in these areas, where the increasing burden of chronic diseases drives the advanced demand for diagnostic technologies.

RECENT DEVELOPMENTS & NEWS:

Technological innovations in augmented reality (AR) and artificial intelligence (AI) for accuracy and precision of procedures represent the most recent trends in the interventional radiology market. Also expanding the marketing horizon is the rising use of optical coherence tomography (OCT) and fractional flow reserve (FFR) in the treatment of coronary artery disease. Government initiatives to create public awareness about the advantages of interventional radiology are driving growth even faster.

KEY PLAYERS:

• Boston Scientific Corporation
• Cook Group Incorporated
• Esaote SpA
• Fujifilm Holdings Corporation
• General Electric Company
• Hologic Inc
• Koninklijke Philips N.V.
• Medtronic plc
• Nipro Corporation
• Shimadzu Corporation
• Siemens Aktiengesellschaft
• Teleflex Incorporated

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most changemakers to create a lasting ambitious impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.